Molecular screening and analysis of Genistein analogues for the identification of novel therapeutic inhibitors against estrogen receptor alpha
DOI:
https://doi.org/10.56511/JIPBS.2018.v5.i02.pp108-112Abstract
Most common malignancy faced by women around the world today is breast cancer. Estrogen receptor alpha has been identified and play a major role in stimulating the growth of breast cancer. So in the present analysis, our focus has been on natural compounds which do not exhibit any toxicity and have significant estrogen receptor alpha inhibition activity. Several reports proposed that polyphenolic chemicals present in many plant foods, and hence these compounds have several chemo preventive properties against breast cancer. So by using molecular docking, we screened the selected natural compounds and investigated their binding affinity against the selected protein. As a result, we predict the novel therapeutic inhibitors against estrogen receptor alpha for the treatment of breast cancer.
Keywords:
Breast cancer, Estrogen receptor alpha, In-Silico, Docking-virtual screening, ADMETDownloads
References
Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hulbert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, O'Connor JP, O'Connor R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM: Critical research gaps and Translational Priorities for the successful Prevention and treatment of breast cancer. Breast Cancer Research 2013; 15(5):R92.
Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, RenehanAG, Forman D, Soerjomataram I: Recent trends in incidence of five commoncancers in 26 European countries since 1988:Analysis of the EuropeanCancer Observatory European. Journal of Cancer 2015; 51(9):1164-87.
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM: Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research 2014; 74:2913 – 2921.
Colditz GA, Bohlke K: Priorities for the primary prevention of breast cancer. CA: Cancer Journal for Clinicians 2014; 64:186 – 194.
Rebacca L, Siegel MPH, Kimberly D, Miller MPH, Ahmedin Jemal DVM: Cancer statistics. CA: Cancer Journal for Clinicians 2017; 67:7-30.
SorliePD, Backlund E and Keller JB: US mortality by economic, demographic, and social characteristics: the National Longitudinal Mortality Study. American Journal of Public Health 1995; 85(7): 949956.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics. CA: Cancer Journal for Clinicians 2015; 65:87-108.
Hurvitz SA, Pietras RJ: Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions. Cancer 2008; 113(9): 2385-2397.
McKeown, N: Antioxidants and breast cancer. Nutrition Reviews 1999; 57:321-324.
Jones KL, Buzdar AU: A review of adjuvant hormonal therapy in breast cancer. Endocrine Related Cancer 2004; 11(3): 391-406.
Dunnwald LK, Rossing MA, Li, CI: Hormone receptor status, Tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Research 2007; 9 (1):R6.
PikeMC, Spicer DV, Dahmoush L, and Press, MF: Estrogens, progesterone‟s, normal breast cell p roliferation and breast cancer risk. Epidemiologic Review 1993; 15(1):17-35.
Welboren WJ, Sweep FC, Span PN, Stunnenberg HG: Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated. Endocrine Related Cancer 2009; 16(4):1073 – 1089.
Shaaban AM, Sloane JP, West CR, Foster CS: Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. The American Journal of Pathology 2002; 160 (2): 597-604.
Davies, G: Time Tables of Medicine. Black Dog & Leventhal. New York: 2000.
Polkowski K,Mazurek AP: Biological properties of Genistein. A review of in vitro and in vivo data: Acta Poloniae Pharmaceutica 2000; 57(2):135 – 155.
Fang CY, Tseng M, Daly MB: Correlates of soy food consumption in women at increased risk for breast cancer. Journal of the American Dietetic Association 2005; 105(10):1552 – 1558.
Dykstra KD, Guo L, Birzin ET, Chan W, Yang YT, Hayes EC, Da Silva CA, Pai LY, Mosley RT, Kraker B, Fitzgerald PM, Di Ninno F, Rohrer SP, Schaeffer JM and Hammond ML: Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ER alpha. Bio organic & Medicinal Chemistry Letters 2007; 17(8):2322 – 2328.
Yanli Wang, Evan Bolton, Svetlana Dracheva, Karen Karapetyan, Benjamin A, Shoemaker, Tugba O, Suzek, Jiyao Wang, Jewen Xiao, Jian Zhang, and Stephen H, Bryant: An overview of the Pubchem bioassay resource. Nucleic acids research 2010; 38:D255 – D266.
DallakyanS, Olson AJ: Small-molecule library screening by docking with PyRx. Chemical Biology 2015; 1263:243 – 250.
Lipinski, CA: "Leadand drug-like compounds: the rule-of-five revolution". Drug Discovery Today. Technologies 2004; 1 (4): 337 – 341.
Lipinski, CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001; 46 (1-3): 3 – 26.
Von Korff M, and Sander T: Toxicity-indicating structural patterns. Journal of Chemical Information & Modeling 2006; 46: 536−544.
Published
How to Cite
Issue
Section
Copyright (c) 2018 Megana. K.S.N.M, Suneetha.Y
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at